1. Home
  2. VTMX vs CGON Comparison

VTMX vs CGON Comparison

Compare VTMX & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • CGON
  • Stock Information
  • Founded
  • VTMX 1998
  • CGON 2010
  • Country
  • VTMX Mexico
  • CGON United States
  • Employees
  • VTMX N/A
  • CGON N/A
  • Industry
  • VTMX
  • CGON
  • Sector
  • VTMX
  • CGON
  • Exchange
  • VTMX Nasdaq
  • CGON NYSE
  • Market Cap
  • VTMX 2.3B
  • CGON 2.1B
  • IPO Year
  • VTMX 2023
  • CGON 2024
  • Fundamental
  • Price
  • VTMX $25.82
  • CGON $26.51
  • Analyst Decision
  • VTMX Sell
  • CGON Strong Buy
  • Analyst Count
  • VTMX 2
  • CGON 10
  • Target Price
  • VTMX $29.00
  • CGON $64.44
  • AVG Volume (30 Days)
  • VTMX 141.0K
  • CGON 793.0K
  • Earning Date
  • VTMX 07-24-2025
  • CGON 08-07-2025
  • Dividend Yield
  • VTMX 2.55%
  • CGON N/A
  • EPS Growth
  • VTMX N/A
  • CGON N/A
  • EPS
  • VTMX 0.13
  • CGON N/A
  • Revenue
  • VTMX $258,927,122.00
  • CGON $662,000.00
  • Revenue This Year
  • VTMX $17.35
  • CGON N/A
  • Revenue Next Year
  • VTMX $11.82
  • CGON $25,206.93
  • P/E Ratio
  • VTMX $19.39
  • CGON N/A
  • Revenue Growth
  • VTMX 15.06
  • CGON 224.51
  • 52 Week Low
  • VTMX $21.30
  • CGON $14.80
  • 52 Week High
  • VTMX $32.84
  • CGON $40.47
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 29.19
  • CGON 54.72
  • Support Level
  • VTMX $27.17
  • CGON $25.80
  • Resistance Level
  • VTMX $27.65
  • CGON $27.56
  • Average True Range (ATR)
  • VTMX 0.49
  • CGON 1.00
  • MACD
  • VTMX -0.15
  • CGON 0.04
  • Stochastic Oscillator
  • VTMX 17.86
  • CGON 67.97

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: